Leerink Partnrs upgraded shares of Genmab A/S (NASDAQ:GMAB – Free Report) from a hold rating to a strong-buy rating in a ...

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has earned an average recommendation of “Buy” from the seven brokerages that ...

According to the Arizona Department of Health Services, RSV cases increased 5.5% the week of Feb. 2-8 from the previous week.

AbbVie (NYSE: ABBV) closed out a pivotal 2024 with an excellent fourth-quarter earnings report. For the period ended Dec. 31, ...

Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...

Leading specialists discuss the increasing prevalence of colorectal diseases in India, highlighting modern treatment ...

Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...

The winter season calls for us to layer up our immune systems by getting current on various vaccines, including flu, COVID-19, and RSV.

为解决复发或难治性高危神经母细胞瘤治疗难题，西班牙巴塞罗那圣琼德乌医院的研究人员开展 Naxitamab 联合 GM-CSF 的 2 期临床试验。结果显示该疗法有效且安全，为患者带来新希望，推荐科研读者阅读。

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

PORTLAND, OR, UNITED STATES, February 15, 2025 /EINPresswire / -- Ankylosing spondylitis (AS) is a chronic inf ...